NCT04998851ocrelizumabmultiple sclerosisWwMS
…SOPRANINO ( NCT04998851) is the first prospective study measuring both pharmacodynamic …
1articles mentioning funders
1funder mentions
1distinct funders extracted
0%of mentions human-reviewed
Active filtersEntity: NCT04998851 ×
NCT04998851
This funder is selected. Its supporting articles are shown below.